Paramètres biologiques   ARV+Placebo ARV+«Spiruline plus» Placebo «Spiruline plus» p (variance) Globules Blancs <Normal 12 (42.8%) 6(23.1%) 3(18.75%) 3(23.1%) 0.450 (n=83)  Normal 15(53.6) 20(76.9%) 13(81.25%) 9(69.2%)     >Normal 1(3.6%) - - 1(7.7%)   Neutrophiles <Normal 9(32.1%) 8(30.8%) 10(62.5%) 7(53.8%) 0.043 (n=82)  Normal 18(64.3%) 18(69.2%) 6(37.5%) 6(46.1%)     >Normal 1(3.6%) - - -   Lymphocytes <Normal 4(14.3%) - - - 0.205 (n=82)  Normal 22(78.6%) 25(100%) 14(87.5%) 13(100%)     >Normal 2(7.1%)   2(12.5%)     Monocytes <Normal 5 (17.8%) 5(19.2%) - - 0.356 (n=82)  Normal 10(35.7%) 6(23.1%) 3(18.8%) 3(25%)     >Normal 13(46.5) 15(57.7%) 13(81.2%) 9(75%)   Eosinophiles <Normal 20(71.4%) 21(84%) 11(68.7) 2(15.4%) 0.07 (n=82) >Normal 8(28.6%) 4(26%) 5(31.3%) 11(84.6%)   Basophiles <Normal 28(100%) 25(96.1%) 16(100%) 13(100%) NC (n=83) > Normal - 1(3.9%) - -   Globules rouges <Normal 22(78.6%) 26 (100%) 6(37.5%) 8(66.7%) 0.112 (n=82)  Normal 6(21.4%) - 10(62.5%) 4(33.3%)     >Normal - - - -   Hémoglobine <Normal 6(21.4%) 6(23.1%) 4(25%) 8(66.7%) 0.133 (n=82)  Normal 22(78.6%) 20(76.9%) 12(75%) 4(33.3%)     >Normal - - - -   Hématocrite <Normal 17(60.7%) 16(64%) 9(56.2%) 9(69.2%) 0.112 (n=82)  Normal 11(39.3%) 9(36%) 6(37.5%) 4(30.8%)     >Normal - - 1(6.3%) -   CCMH <Normal - 1(4%) - -   (n=82)  Normal 2((7.1%) - 8(50%) 3(25%)     >Normal 26(82.9%) 25(96%) 8(50%) 9(75%)   TGMH <Normal - - 1(6.7%) -   (n=82)  Normal 1(3.6%) 4(15.4%) 2(13.3%) 1(8.3%)     >Normal 27(96.4%) 22(84.6%) 12(80%) 11(91.7%)   Plaquettes <Normal 3(10.7%) 5(19.2%) 4(25%) - 0.848 (n=82)  Normal 25(89.3%) 21(80.8%) 12(75%) 13(100%)     >Normal - - - -   VGM <Normal - 1(3.8%) 2(12.5%) 1(8.3%)   (n=82)  Normal 9(32.1%) 10(38.5%) 12(75%) 8(66.6%)     >Normal 19(67.8%) 15(57.7%) 2(12.5%) 3(25%)

Table 8: Hematological features in the treatment group and normal intervals to 6 months follow-up.